35 Non-Tech AI Opportunities Amid DeepSeek Selloff

Page 18 of 35

18. DaVita Inc. (NYSE:DVA)

Number of Hedge Fund Holders: 39     

DaVita Inc. (NYSE:DVA) provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. This company stands out as a rewarding investment for several reasons. The most influential factor is the strong financial performance in the report for the third quarter of 2024. For instance, reported consolidated revenues were $3.2 billion, which shows the scale of the company’s business activities and its ability to generate sales. Additionally, operating income was $535 million, which reflects the company’s ability to generate profit from its core operations, excluding non-operational items such as taxes and interest. Also, diluted earnings per share was $2.50 and adjusted diluted earnings per share was $2.59, which represents the company’s ability to generate profits for its shareholders. Moreover, DaVita has been actively integrating AI to enhance patient care. The company is developing over 40 AI models, which would improve treatment outcomes and early detection of chronic illnesses.

Page 18 of 35